Richard Schapiro - Molina Healthcare Independent Director
| MOH Stock | USD 296.07 1.43 0.49% |
Director
Mr. Richard M. Schapiro is an Independent Director of the Company. In 2018, Mr. Schapiro achieved Board Leadership Fellow status, completed the NACD Carnegie Mellon CyberSecurity Course and was selected for inclusion in the 2018 NACD Directorship100, recognizing individual directors who serve as role models promoting exemplary board leadership, oversight, and courage in the boardroom. Since April 2015, served as Chief Executive Officer of SchapiroCo LLC. Since January 2017, served as an independent director for Transamerica Corporationrationration, and from April 2015 to January 2017, served as independent director for Transamerica Financial Life Insurance Company. From 1999 to 2014, served as a Managing Director in the Corporationrationrate and Investment Banking Division of Bank of America Merrill Lynchs Health Care Group . From 1997 to 1999, served as Managing Director and Head of Health Care Group for ING Baring Furman Selz. From 1979 to 1997, held various positions at Salomon Brothers Inc., serving as Managing Director and Global CoHead of the Health Care Group, Managing Director Insurance Group, Managing Director and Head of Government Finance Group, and Managing Director and Head of Thrift Coverage Group. chelor of Science Degree in Accounting from Case Western Reserve University. sters Degree in Business Administration from Bernard M. Baruch College. Juris Doctorate from New York Law School since 2015.
| Age | 65 |
| Tenure | 9 years |
| Address | 200 Oceangate, Long Beach, CA, United States, 90802 |
| Phone | 562 435 3666 |
| Web | https://www.molinahealthcare.com |
Molina Healthcare Management Efficiency
The company has Return on Asset of 0.069 % which means that on every $100 spent on assets, it made $0.069 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2645 %, implying that it generated $0.2645 on every 100 dollars invested. Molina Healthcare's management efficiency ratios could be used to measure how well Molina Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The Molina Healthcare's current Return On Capital Employed is estimated to increase to 0.43, while Return On Tangible Assets are projected to decrease to 0.07. As of now, Molina Healthcare's Other Current Assets are increasing as compared to previous years. The Molina Healthcare's current Non Current Assets Total is estimated to increase to about 2.5 B, while Intangible Assets are projected to decrease to under 120.3 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| George Kurian | Cigna Corp | 54 | |
| Marissa Peterson | Humana Inc | 58 | |
| John Noseworthy | UnitedHealth Group Incorporated | 69 | |
| Frederick Eppinger | Centene Corp | 62 | |
| Karen Katz | Humana Inc | 64 | |
| Valerie Rice | UnitedHealth Group Incorporated | 58 | |
| NancyAnn DeParle | CVS Health Corp | 64 | |
| Mark McClellan | Cigna Corp | 57 | |
| John Roberts | Centene Corp | 78 | |
| Siddhartha Sankaran | Oscar Health | 46 | |
| Tommy Thompson | Centene Corp | 78 | |
| John Partridge | Cigna Corp | 71 | |
| Tony White | CVS Health Corp | 73 | |
| Eric Wiseman | Cigna Corp | 65 | |
| Frank DAmelio | Humana Inc | 63 | |
| William McDonald | Humana Inc | 64 | |
| Glenn Renwick | UnitedHealth Group Incorporated | 64 | |
| Eric Foss | Cigna Corp | 62 | |
| William Trubeck | Centene Corp | 74 | |
| David Steward | Centene Corp | 68 | |
| Alecia DeCoudreaux | CVS Health Corp | 66 | |
Management Performance
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.069 |
Molina Healthcare Leadership Team
Elected by the shareholders, the Molina Healthcare's board of directors comprises two types of representatives: Molina Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Molina. The board's role is to monitor Molina Healthcare's management team and ensure that shareholders' interests are well served. Molina Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Molina Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph CFA, Senior Relations | ||
| Jason Dees, Executive Vice President - Marketplace | ||
| James Woys, Executive Vice President - Health Plan Services | ||
| Maurice CPA, Chief Officer | ||
| Garrey Carruthers, Independent Director | ||
| Brian Maddy, President - Oklahoma | ||
| FAAFP DO, Executive Officer | ||
| Joseph Zubretsky, President, Chief Executive Officer, Director | ||
| David Reynolds, Senior Plans | ||
| Esq JD, Chief Sec | ||
| Thomas Tran, Chief Financial Officer, Treasurer | ||
| John Kotal, Chief California | ||
| Richard Zoretic, Independent Director | ||
| Dale Wolf, Non-Executive Independent Director | ||
| Maurice Hebert, Chief Accounting Officer | ||
| Mark Keim, Executive Vice President - Executive Vice President Strategic Planning, Corporate Development & Transformation | ||
| Jeffrey Geyer, Head Relations | ||
| Stephen Lockhart, Independent Director | ||
| Barbara Brasier, Independent Director | ||
| Richard Schapiro, Independent Director | ||
| Jeff Barlow, Senior Vice President General Counsel, Secretary | ||
| Joann ZarzaGarrido, Vice Compliance | ||
| Dave Reynolds, Senior Vice President - Health Plans | ||
| Keith Wilson, Chief Officer | ||
| Daniel Cooperman, Non-Executive Independent Director | ||
| Ronna Romney, Independent Vice Chairman of the Board | ||
| Larry Anderson, Executive Officer | ||
| David Pollack, VP Operations | ||
| Marc Russo, Executive Vice President - Medicaid Health Plans | ||
| Keith MD, Chief Officer | ||
| Steven Orlando, Independent Director |
Molina Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Molina Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.069 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 10.17 B | ||||
| Shares Outstanding | 57.2 M | ||||
| Shares Owned By Insiders | 1.13 % | ||||
| Shares Owned By Institutions | 99.85 % | ||||
| Number Of Shares Shorted | 888.43 K | ||||
| Price To Earning | 26.49 X |
Currently Active Assets on Macroaxis
When determining whether Molina Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Molina Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Molina Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Molina Healthcare Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molina Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Molina Stock please use our How to Invest in Molina Healthcare guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molina Healthcare. If investors know Molina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molina Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.342 | Earnings Share 19.66 | Revenue Per Share 649.831 | Quarterly Revenue Growth 0.174 | Return On Assets 0.069 |
The market value of Molina Healthcare is measured differently than its book value, which is the value of Molina that is recorded on the company's balance sheet. Investors also form their own opinion of Molina Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Molina Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molina Healthcare's market value can be influenced by many factors that don't directly affect Molina Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molina Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Molina Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molina Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.